Outlook Therapeutics, Inc. business relationships
Companies named in Outlook Therapeutics, Inc.’s 10-K filed 2025-12-19, and public companies whose annual reports name Outlook Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 9 / 100 Top 4% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Outlook Therapeutics, Inc.’s annual report 2
“Establishing additional or replacement vendors, including FUJIFILM, if required, may not be accomplished quickly.” SEC filing
“In the event that any of our license agreements or our strategic relationship with Cencora terminates, we may need to find another partner in those markets to commercialize and in certain instances, manufacture any product candidates.” SEC filing
Links are read automatically from public company filings, so every link carries the sentence it came from.
Not investment advice. Scores, rankings and connections are automated estimates from public sources, provided as is. Connections are read automatically from public company filings and may be incomplete or wrong. To correct or remove a company page or a connection, email [email protected]. Company names and logos belong to their owners. Showing them does not mean the company endorses Engagemii or that Engagemii endorses it. Terms